Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?

Group 1 - Butterfly Network, Inc. (BFLY) has shown a year-to-date performance increase of approximately 39.8%, significantly outperforming the Medical sector's average return of 11.7% [4] - The Zacks Consensus Estimate for BFLY's full-year earnings has risen by 11.9% over the past 90 days, indicating improving analyst sentiment and a positive earnings outlook [4] - Butterfly Network, Inc. currently holds a Zacks Rank of 2 (Buy), suggesting it has characteristics that may lead to outperformance in the market over the next one to three months [3] Group 2 - Butterfly Network, Inc. is part of the Medical Info Systems industry, which consists of 41 companies and is currently ranked 69 in the Zacks Industry Rank [6] - The Medical Info Systems industry has experienced a decline of about 10.6% year-to-date, indicating that BFLY is performing better than its industry peers [6] - In comparison, Brainsway Ltd. Sponsored ADR, another outperforming stock in the Medical sector, has increased by 17% year-to-date and has a Zacks Rank of 1 (Strong Buy) [5][7]